Economic evaluation of cell salvage in pediatric surgery

Paediatric Anaesthesia

Volumn 23, Issue 11, 2013, Pages 1027-1034

  Samnaliev, Mihail ^a   Tran, Chau M ^a   Sloan, Steven R ^a   Gasior, Izabela ^a   Lightdale, Jenifer R ^a   Brustowicz, Robert M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

blood transfusion; children; cost effectiveness; cost savings; intraoperative blood cell salvage

Indexed keywords

ADOLESCENT; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD TRANSFUSION; BODY WEIGHT; COST CONTROL; ECONOMIC EVALUATION; ELECTIVE SURGERY; ERYTHROCYTE; HEALTH CARE COST; HEART SURGERY; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; OPERATIVE BLOOD LOSS; ORTHOPEDIC SURGERY; PEDIATRIC SURGERY; PRIORITY JOURNAL; SURGICAL PATIENT;

BLOOD TRANSFUSION; CHILDREN; COST-EFFECTIVENESS; COST-SAVINGS; INTRAOPERATIVE BLOOD CELL SALVAGE;

BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; COST SAVINGS; COST-BENEFIT ANALYSIS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; FEMALE; HUMANS; INFANT; INFECTION; INTRAOPERATIVE CARE; LABORATORY PERSONNEL; MALE; MODELS, STATISTICAL; OPERATIVE BLOOD SALVAGE; ORTHOPEDIC PROCEDURES; POSTOPERATIVE COMPLICATIONS;

EID: 84885185585     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12233     Document Type: Article

References (24)

1. Wang G, Bainbridge D, Martin J, et al,. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109: 320-330.
2. Krajewski K, Ashley RK, Pung N, et al,. Successful blood conservation during craniosynostotic correction with dual therapy using procrit and cell saver. J Craniofac Surg 2008; 19: 101-105.
3. Golab HD, Scohy TV, de Jong PL, et al,. Intraoperative cell salvage in infants undergoing elective cardiac surgery: a prospective trial. Eur J Cardiothorac Surg 2008; 34: 354-359.
4. Dahmani S, Orliaguet GA, Meyer PG, et al,. Perioperative blood salvage during surgical correction of craniosynostosis in infants. Br J Anaesth 2000; 85: 550-555.
5. Bowen RE, Gardner S, Scaduto AA, et al,. Efficacy of intraoperative cell salvage systems in pediatric idiopathic scoliosis patients undergoing posterior spinal fusion with segmental spinal instrumentation. Spine (Phila Pa 1976) 2010; 35: 246-251.
6. Lavoie J,. Blood transfusion risks and alternative strategies in pediatric patients. Pediatr Anesth 2010; 21: 14-24.
7. Davies L, Brown TJ, Haynes S, et al,. Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. Health Technol Assess 2006; 10: iii-Iv, ix-X, 1-210.
8. Waters JR, Meier HH, Waters JH,. An economic analysis of costs associated with development of a cell salvage program. Anesth Analg 2007; 104: 869-875.
9. Savvidou C, Chatziioannou SN, Pilichou A, et al,. Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. Transfus Med 2009; 19: 202-206.
10. Boese CK, Gallo TJ, Weis M, et al,. Efficacy and cost-effectiveness of a blood salvage system in primary total knee arthroplasty-a retrospective match-controlled chart review. Iowa Orthop J 2011; 31: 78-82.
11. Attaran S, McIlroy D, Fabri BM, et al,. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases. Interact Cardiovasc Thorac Surg 2010; 12: 824-826.
12. Munoz M, Campos A, Munoz E, et al,. Red Cell Salvage in Orthopaedic Surgery. Transfus Altern Transfus Med 2005; 8: 41-51.
13. Toner RW, Pizzi L, Leas B, et al,. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Appl Health Econ Health Policy 2011; 9: 29-37.
14. The 2009 National Blood Collection and Utilization Survey Report. Washington DC: US Department of Health and Human Services, Office of the Assistant Secretary for Health; 2011.
15. Amin M, Fergusson D, Aziz A, et al,. The cost of allogeneic red blood cells-a systematic review. Transfus Med 2003; 13: 275-285.
16. Huet C, Salmi LR, Fergusson D, et al,. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89: 861-869.
17. Despotis G, Eby C, Lublin DM,. A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 2008; 48 (Suppl 1): 2S-30S.
18. Kleinman SH, Kuhns MC, Todd DS, et al,. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003; 43: 696-704.
19. Bihl F, Castelli D, Marincola F, et al,. Transfusion-transmitted infections. J Transl Med 2007; 5: 25.
20. Pereira A,. Health and economic impact of posttransfusion hepatitis B and cost-effectiveness analysis of expanded HBV testing protocols of blood donors: a study focused on the European Union. Transfusion 2003; 43: 192-201.
21. Salomon JA, Weinstein MC, Hammitt JK, et al,. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population. JAMA 2003; 290: 228-237.
22. Dwyre DM, Fernando LP, Holland PV,. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century. Vox Sang 2010; 100: 92-98.
23. Schackman BR, Gebo KA, Walensky RP, et al,. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44: 990-997.
24. Herwaldt BL, Linden JV, Bosserman E, et al,. Transfusion-associated babesiosis in the United States: a description of cases. Ann Intern Med 2011; 155: 509-519.